Eastar Chemical Corporation

AGC Chemicals Americas is a wholly owned subsidiary of AGC Inc., a $14 billion multinational corporation and one of the world’s largest manufacturers of glass, electronic displays and chemical products.

AGC Chemicals Americas, Inc. manufactures, markets and sells fluoroproducts including Fluon® fluoropolymer resins, Fluon+™ enhanced fluorinated materials and compounds, AFLAS® fluoroelastomers and AsahiKlin fluorinated solvents. The company also markets and sells specialty chemicals and materials including LUMIFLON® FEVE resins, AsahiGuard E-SERIES water and oil repellants, Fluon ETFE film, F-CLEAN® greenhouse films, Solesphere™ fine silica additives and various fluoro intermediates for pharma and agro products.

AGC Chemicals Americas was formed in 2004 through the merging of sister companies Asahi Glass Fluoropolymers USA and AGA Chemicals. Headquartered in Exton, Pa., including a state-of-the-art technology center, AGC Chemicals Americas maintains manufacturing operations in nearby Thorndale, Pa., a satellite sales office in Sao Paulo, Brazil and warehouses located throughout North America.

We are pleased to offer R&D services and technical support from our Business and Technical Center as part of our business development and technical solutions strategies.

Our mission can be summarized in the following phrase: "Your Dreams, Our Challenge."​ Working with others to combine knowledge and advanced technology, we create unique materials, solutions and reliable partnerships that help make ever greater achievements possible, and bring bolder ideas to life.

We invite you to further explore our web site to see how products from AGC Chemicals Americas can make a difference in your businesses.

Dow combines global breadth, asset integration and scale, focused innovation, and leading business positions to achieve profitable growth. Our ambition is to become the most innovative, customer-centric, inclusive, and sustainable materials science company, with a purpose to deliver a sustainable future for the world through our materials science expertise and collaboration with our partners. Our portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility, and consumer care. We operate 106 manufacturing sites in 31 countries and employ approximately 35,700 people.

A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients.

ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals

API MANUFACTURING:
Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our focus is providing bulk (Schedule II–V) controlled actives, however non-controlled APIs are also within our project portfolio.

ANALYTICAL SERVICES:
Apertus performs analytical methods development and services on a variety of instrument platforms. Our primary focus is LC (UV), LCMS and GCMS. We can use existing methods or develop novel methods on a per-project basis. In addition, we can provide methods validation, impurity identification and tech transfer packages.

PHARMACEUTICAL SERVICES:
Apertus provides services for drug discovery and preclinical development on a kilo-lab scale. We can supply intermediates, specialty chemical synthesis, process optimization and scale-up services. In addition we can aid in characterizing RLDs via dissolution profiles, chemical analysis and microscopy. All services can be provided under cGMP if desired.

BoroPharm Inc. is an environmentally conscious US specialty chemical company serving the pharmaceutical, agrotech, and fine chemical industries. We specialize in offering solutions to your sourcing problems, by manufacturing difficult to source heterocycles, intermediates and registered starting materials. We offer route scouting services, route optimization services, and full contract and custom manufacturing services up to 100 metric ton scale. The value we offer our customers is guaranteeing peace of mind throughout the entire supply chain lifecycle. We guarantee your products will be delivered on time, on spec, and on budget. Whether you are having difficulties with existing vendors for a particular compound, seeking a secondary supplier, or simply can not find a supplier for a particular product, let BoroPharm surprise you!